An experimental drug targeting a common mutation in melanoma successfully shrank tumors that spread to the brain in nine out of 10 patients in part of an international phase I clinical trial report.

Source: Phase I clinical trial shows drug shrinks melanoma brain metastases


David Cottle

UBB Owner & Administrator